the annual report states that there is a going concern issuethis has still not been addressedIm stunned (with that qualificatin on the audit), that the company is still trading, let alone discussions on valuation...?!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%